ZEB2 and cancer: Given that the Wnt/β-catenin pathway is associated with cancer cell aggressiveness, and ZEB2 is presumably related to metastatic capability, multiple biomarker-positive cancer cells might be related to the presence of aggressive subpopulations of cancer cells, which are potentially localized at the invasive margin of HNSCC tumors.